An observational study in Hip Osteoarthritis and Knee Osteoarthristis, sponsored by Horsens Hospital. Recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-26.
Sponsored by Horsens Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Osteoarthritis, Hip with a site in Denmark — 2 open to participants now, 9 under way, none of them phase 3. Osteoarthritis, Hip · Denmark.
Among the 34 studies in Osteoarthritis, Hip with a site in Denmark, this one is the only one that started in 2025, is one of 6 observational ones, and was the 34th registered.
642 studies on the registry are indexed under Osteoarthritis, Hip; 120 are open to participants now.
Browse Osteoarthritis, Hip studies →2 of the 34 studies in Osteoarthritis, Hip with a site in Denmark are open now. Recruiting first, the newest first:
Northern Orthopaedic Division, Denmark · Sites in Denmark
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 86 Osteoarthritis, Hip studies recruiting now, 53 (62%) set no upper age limit and 7 (8%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 84 is below the median of 135 across 158 observational studies indexed under Osteoarthritis, Hip.
Median enrollment 134 across the 28 interventional studies, 93 across the 6 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 34 have an industry lead sponsor. The 10 most frequent:
Horsens Hospital is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Horsens Hospital has 1 study filed under Osteoarthritis, Hip — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 34 studies in Osteoarthritis, Hip with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Patients with total hip or knee replacement experiencing persistant problems are offered 3 weeks of intensive rehabilitation.
Outcomes before, at the end of treatment and at 6 months follow up will be investigated. Data will be handled separately for the two groups of patients: 42 with a total hip replacement and 42 with a total knee replacement. Specific and generic outcomes will be collected.
Patients who have a total hip or knee replacement experiencing persistant problems, hence are admitted to a 3 week intensive rehabilitation period.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
- Patients with a total hip or knee replacement admitted for intensive rehabilitation
Exclusion Criteria:
Patients with a total hip replacement undergoing rehabilitation
Other: Rehabilitation
Patients with a total hip replacement undergoing rehabilitation
Other: Rehabilitation
Three weeks intensive rehabilitation where patients undergo group-based and individualised rehabilitation focusing at improving pain, function and quality of life for the patient
HOOS/KOOS pain (0-100 score)
Hip or knee related pain
Time frame: Change from baseline (0) to 3 weeks
HOOS/KOOS ADL (0-100 score)
Hip or knee related activities of daily living
Time frame: Change from baseline (0) to 3 weeks
HOOS/KOOS quality of life (0-100 score)
Hip or knee related quality of life
Time frame: Change from baseline (0) to 3 weeks
HOOS/KOOS pain (0-100 score)
Hip or knee related pain
Time frame: Change from 3 weeks to 7 months
HOOS/KOOS ADL (0-100 score)
Hip or knee related activities of daily living
Time frame: Change from 3 weeks to 7 months
HOOS/KOOS quality of life (0-100 score)
Hip or knee related quality of life
Time frame: Change from 3 weeks to 7 months
Sit-to-stand test
Number of completed sit to stands in 30 seconds
Time frame: Change from baseline (0) to 3 weeks
Sit-to-stand test
Number of completed sit to stands in 30 seconds
Time frame: Change from 3 weeks to 7 months
Patient acceptable symptom state (yes/no)
Patients are asked with a single question if their current symptom state is acceptable
Time frame: 3 weeks follow up
Patient acceptable symptom state (yes/no)
Patients are asked with a single question if their current symptom state is acceptable
Time frame: 7 months follow up
Pain catastrophising scale (0-52 score)
Current level of pain catastrophising with 0 being the best
Time frame: Baseline
Pain catastrophising scale (0-52 score)
Current level of pain catastrophising with 0 being the best
Time frame: 3 weeks
Pain catastrophising scale (0-52 score)
Current level of pain catastrophising with 0 being the best
Time frame: 7 months
Global rating of change (0-11 score)
Likert scale where patients indicate their overall rating of change since the beginning of the intervention
Time frame: Change from baseline to 3 weeks
Global rating of change (0-11 score)
Likert scale where patients indicate their overall rating of change since the beginning of the intervention
Time frame: Change from baseline to 7 months
The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)
EQ5D5L scores
Time frame: Change from baseline (0) to 3 weeks
The 5-level EQ-5D version (EQ-5D-5L) (0-5 scale)
EQ5D5L scores
Time frame: Change from 3 weeks to 7 mothns
EQ5D VAS (0-100 scale)
EQ5D Vas overall health
Time frame: Change from baseline (0) to 3 weeks
EQ5D VAS (0-100 scale)
EQ5D Vas overall health
Time frame: Change from 3 weeks to 7 months
HOOS/KOOS symptoms (0-100 score)
Hip or knee related symptoms
Time frame: Change from baseline (0) to 3 weeks
HOOS/KOOS symptoms (0-100 score)
Hip or knee symptoms
Time frame: Change from 3 weeks to 7 months
HOOS/KOOS sport/rec (0-100 score)
Hip or knee related sport/rec
Time frame: Change from baseline (0) to 3 weeks
HOOS/KOOS sport/rec (0-100 score)
Hip or knee related sport/rec
Time frame: Change from 3 weeks to 7 months
6 minute walk test
The distance a patient can walk in 6 minutes
Time frame: Change from baseline (0) to 3 weeks
6 minute walk test
The distance a patient can walk in 6 minutes
Time frame: Change from 3 weeks to 7 months
40 meter fast paced walk test
The time a patient uses walking 40 meters fast
Time frame: Change from baseline (0) to 3 weeks
40 meter fast paced walk test
The time a patient uses walking 40 meters fast
Time frame: Change from 3 weeks to 7 months
Stair test
The time a patient uses to ascend and decend a staircase
Time frame: Change from baseline (0) to 3 weeks
Stair test
The time a patient uses to ascend and decend a staircase
Time frame: Change from 3 weeks to 7 months
Patient acceptable symptom state (yes/no)
Patients are asked with a single question if their current symptom state is acceptable
Time frame: Baseline
Employment status (yes/no/part time)
Time frame: Baseline
Employment status (yes/no/part time)
Time frame: 7 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2027, 28 months after the start.
Of 52 non-industry observational studies under Osteoarthritis, Hip, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 59. This study's planned 28 months is above that.
Counting every sponsor, half of 81 studies reached it within 53 months; a quarter within 13 and three quarters within 113.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Horsens Hospital